Clinical Trial Update: Serial Retinal Thickness Changes And Scotoma Size Measured With Lucentis Therapy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update evaluating serial retinal thickness changes and scotoma size in patients with age-related macular degeneration treated with Luce…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration

Drugs mentioned

• Lucentis (ranibizumab)

Snippet

Sponsor: The New York Eye & Ear Infirmary | Conditions: Age Related Macular Degeneration | Phase 3 | Status: UNKNOWN